[HTML][HTML] Nimotuzumab: beyond the EGFR signaling cascade inhibition

Z Mazorra, L Chao, A Lavastida, B Sanchez… - Seminars in …, 2018 - Elsevier
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …

Nimotuzumab: beyond the EGFR signaling cascade inhibition

Z Mazorra, L Chao, A Lavastida… - Seminars in …, 2018 - pubmed.ncbi.nlm.nih.gov
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …

Nimotuzumab: beyond the EGFR signaling cascade inhibition.

Z Mazorra, L Chao, A Lavastida, B Sanchez… - Seminars in …, 2018 - europepmc.org
One of the most known oncogenes is the epidermal growth factor receptor (EGFR) family. It
activates multiple signaling cascades that promote carcinogenesis and immune evasion …